The forecast for leukemia mortality among women in the U.S. indicates a steady decline from 2024 to 2028. The mortality rate remains at 5.0 in 2024 and 2025, then modestly decreases to 4.9 and 4.8 in subsequent years. Compared to 2023, where actual data is necessary for precise comparisons, the trend suggests improvement in treatment and early detection. Year-on-year variation signals a minor consistent decline, and the five-year CAGR points to a gradual improvement.
Future trends to monitor include advancements in leukemia treatment technologies, increased accessibility to healthcare, and public health initiatives promoting early screenings. These factors could further impact the downward trend positively.
